Improved financial results for radiopharmaceutical developer Palatin Technologies still resulted in a net loss of $1.8 million for the quarter (end-March 31), down from a $3 million net loss posted for the same period last year.
The Princeton, NJ-based firm also reported a net loss of $6 million for the first nine months of the fiscal year, lower than the $8.1 million net loss reported for the same period in 1999. The company attributed the lower net loss to its collaboration with Hazelwood, MO-based Mallinckrodt and cost sharing in the development of LeuTech, a radiolabeled infection imaging kit.
By AuntMinnie.com staff writers
May 10, 2000
